irinotecan has been researched along with a-1331852 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boghaert, ER; Bruncko, M; Catron, ND; Choo, EF; Diaz, D; Doherty, GA; Elmore, SW; Fairbrother, WJ; Flygare, JA; Frey, RR; Gao, W; Hansen, TM; Judd, AS; Judge, RA; Kovar, P; Kunzer, AR; Le, PN; Leverson, JD; Mitten, MJ; Nimmer, P; Park, CH; Phillips, DC; Sampath, D; Shekhar, S; Smith, ML; Song, X; Souers, AJ; Tahir, SK; Tao, ZF; Wang, L; Wang, X; Wendt, MD; Xiao, Y; Xue, J; Zhang, H | 1 |
1 other study(ies) available for irinotecan and a-1331852
| Article | Year |
|---|---|
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X
Topics: | 2020 |